Anti-HER2 therapy efficacy in HER2-negative metastatic breast cancer with HER2-amplified circulating tumor cells: results of the CirCe T-DM1 trial (117P) - Bidard, F-C; Cottu, P; Dubot, C (Ann Oncol, 2017)